Notice of Partnership Agreement for the Development of Transdermal Absorption Formulations of Antibody-Induced Peptides

Section Heading

This release announces the signing of a joint research agreement with the Artience Group to strengthen collaboration. The development of transdermal delivery formulations of antibody-inducing peptides aims to have FanPep conduct efficacy and safety evaluations in animal studies, while Toyo Chemical conducts consideration of transdermal formulation. FanPep bears the research costs, and there is no change to the R&D expense forecast for the fiscal year ending December 2026.

Section 2 Heading

This collaboration aims to advance the next-generation formulation technology of low-invasiveness transdermal delivery systems, and is strategically important for investors as it strengthens the long-term R&D pipeline and market deployment. Specific timelines and performance metrics are not disclosed in this release, but progress updates, additional funding allocations, and milestone announcements are anticipated.